Denmark
· Delayed Price · Currency is DKK Novo Nordisk Statistics
Total Valuation
Novo Nordisk has a market cap or net worth of DKK 1.82 trillion. The enterprise value is 1.90 trillion.
| Market Cap | 1.82T |
| Enterprise Value | 1.90T |
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
Novo Nordisk has 4.44 billion shares outstanding. The number of shares has decreased by -0.71% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 4.44B |
| Shares Change (YoY) | -0.71% |
| Shares Change (QoQ) | -0.11% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 33.88% |
| Float | 3.18B |
Valuation Ratios
The trailing PE ratio is 18.12 and the forward PE ratio is 15.30. Novo Nordisk's PEG ratio is 0.94.
| PE Ratio | 18.12 |
| Forward PE | 15.30 |
| PS Ratio | 6.27 |
| PB Ratio | 12.69 |
| P/TBV Ratio | 56.19 |
| P/FCF Ratio | 24.67 |
| P/OCF Ratio | 15.05 |
| PEG Ratio | 0.94 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.80, with an EV/FCF ratio of 25.70.
| EV / Earnings | 18.78 |
| EV / Sales | 6.53 |
| EV / EBITDA | 12.80 |
| EV / EBIT | 13.56 |
| EV / FCF | 25.70 |
Financial Position
The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.72.
| Current Ratio | 0.74 |
| Quick Ratio | 0.52 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | 0.69 |
| Debt / FCF | 1.39 |
| Interest Coverage | 85.29 |
Financial Efficiency
Return on equity (ROE) is 80.78% and return on invested capital (ROIC) is 46.03%.
| Return on Equity (ROE) | 80.78% |
| Return on Assets (ROA) | 22.41% |
| Return on Invested Capital (ROIC) | 46.03% |
| Return on Capital Employed (ROCE) | 56.34% |
| Revenue Per Employee | 3.78M |
| Profits Per Employee | 1.31M |
| Employee Count | 77,349 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 1.20 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.99% in the last 52 weeks. The beta is 0.25, so Novo Nordisk's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | -53.99% |
| 50-Day Moving Average | 527.08 |
| 200-Day Moving Average | 722.71 |
| Relative Strength Index (RSI) | 33.59 |
| Average Volume (20 Days) | 6,224,170 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novo Nordisk had revenue of DKK 290.40 billion and earned 100.99 billion in profits. Earnings per share was 22.63.
| Revenue | 290.40B |
| Gross Profit | 246.84B |
| Operating Income | 139.88B |
| Pretax Income | 127.19B |
| Net Income | 100.99B |
| EBITDA | 146.67B |
| EBIT | 139.88B |
| Earnings Per Share (EPS) | 22.63 |
Balance Sheet
The company has 26.31 billion in cash and 102.79 billion in debt, giving a net cash position of -76.48 billion or -17.23 per share.
| Cash & Cash Equivalents | 26.31B |
| Total Debt | 102.79B |
| Net Cash | -76.48B |
| Net Cash Per Share | -17.23 |
| Equity (Book Value) | 143.49B |
| Book Value Per Share | 32.31 |
| Working Capital | -56.63B |
Cash Flow
In the last 12 months, operating cash flow was 120.97 billion and capital expenditures -47.16 billion, giving a free cash flow of 73.80 billion.
| Operating Cash Flow | 120.97B |
| Capital Expenditures | -47.16B |
| Free Cash Flow | 73.80B |
| FCF Per Share | 16.63 |
Margins
Gross margin is 85.00%, with operating and profit margins of 48.17% and 34.78%.
| Gross Margin | 85.00% |
| Operating Margin | 48.17% |
| Pretax Margin | 43.80% |
| Profit Margin | 34.78% |
| EBITDA Margin | 50.51% |
| EBIT Margin | 48.17% |
| FCF Margin | 25.41% |
Dividends & Yields
This stock pays an annual dividend of 11.40, which amounts to a dividend yield of 2.79%.
| Dividend Per Share | 11.40 |
| Dividend Yield | 2.79% |
| Dividend Growth (YoY) | 21.28% |
| Years of Dividend Growth | 7 |
| Payout Ratio | 43.71% |
| Buyback Yield | 0.71% |
| Shareholder Yield | 3.49% |
| Earnings Yield | 5.55% |
| FCF Yield | 4.05% |
Stock Splits
The last stock split was on September 13, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Sep 13, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Novo Nordisk has an Altman Z-Score of 8.94.
| Altman Z-Score | 8.94 |
| Piotroski F-Score | n/a |